Dr Nancy Davis King, MD | |
125 Newbern Cir, Auburndale, FL 33823-3348 | |
(863) 965-1288 | |
(863) 967-1297 |
Full Name | Dr Nancy Davis King |
---|---|
Gender | Female |
Speciality | Preventive Medicine - Preventive Medicine/occupational Environmental Medicine |
Location | 125 Newbern Cir, Auburndale, Florida |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1427127315 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083P0500X | Preventive Medicine - Preventive Medicine/occupational Environmental Medicine | ME0058218 (Florida) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Nancy Davis King, MD 125 Newbern Cir, Auburndale, FL 33823-3348 Ph: (863) 965-1288 | Dr Nancy Davis King, MD 125 Newbern Cir, Auburndale, FL 33823-3348 Ph: (863) 965-1288 |
News Archive
Express Scripts, Inc. announced that it has entered into two accelerated share repurchase, or ASR, transactions with Morgan Stanley to purchase shares of Express Scripts' common stock for an aggregate purchase price of $1,750 million. Under the terms of the transactions, the Company will initially receive approximately 29.4 million shares of its stock.
The Lancet Infectious Diseases recently published the results of an observational study led by researchers on Children's Hospital Colorado Infectious Disease and Neurology teams, along with counterparts at the Centers for Disease Control and Colorado Department of Public Health and Environment.
Researchers at Washington University School of Medicine in St. Louis have identified a potential target for treating diabetes and obesity.
Researchers from Duke University's Medical Center and Pratt School of Engineering have demonstrated that they can grow new human blood vessels from cells taken from patients who especially need such assistance – older adults with cardiovascular disease.
› Verified 7 days ago